Aeris Therapeutics Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees

  • Latest Deal Type
  • M&A

Aeris Therapeutics General Information

Description

Developer of medical therapeutics for patients with emphysema and other lung diseases. The company offers therapeutics to reduce lung volume in order to improve lung function in patients with emphysema and allows physicians to use a bronchoscope for the direct treatment to the damaged areas of the patient's lungs.

Contact Information

Website
www.aerist.com
Formerly Known As
Bistech
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 10K Gill Street
  • Woburn, MA 01801
  • United States
+1 (781)
Primary Industry
Therapeutic Devices
Acquirer
Pulmonx
Corporate Office
  • 10K Gill Street
  • Woburn, MA 01801
  • United States
+1 (781)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aeris Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 08-Jan-2015 Completed Generating Revenue
1. Later Stage VC (Series D) Completed Startup
To view Aeris Therapeutics’s complete valuation and funding history, request access »

Aeris Therapeutics Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • Pending

  • Expiring in next 12 mo

Aeris Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20040038868-A1 Administering, by way of the patient's trachea, to the target region of the patient's lung, an anti-surfactant, whereafter the target region collapses and one portion of the target region adheres to another portion of the target region Active 23-Aug-1999
US-6682520-B2 Tissue volume reduction Inactive 23-Aug-1999
US-6610043-B1 Tissue volume reduction Inactive 23-Aug-1999 A61K38/363

Aeris Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Aeris Therapeutics FAQs

  • When was Aeris Therapeutics founded?

    Aeris Therapeutics was founded in 2004.

  • Where is Aeris Therapeutics headquartered?

    Aeris Therapeutics is headquartered in Woburn, MA.

  • What is the size of Aeris Therapeutics?

    Aeris Therapeutics has 11 total employees.

  • What industry is Aeris Therapeutics in?

    Aeris Therapeutics’s primary industry is Therapeutic Devices.

  • Is Aeris Therapeutics a private or public company?

    Aeris Therapeutics is a Private company.

  • What is Aeris Therapeutics’s current revenue?

    The current revenue for Aeris Therapeutics is .

  • When was Aeris Therapeutics acquired?

    Aeris Therapeutics was acquired on 08-Jan-2015.

  • Who acquired Aeris Therapeutics?

    Aeris Therapeutics was acquired by Pulmonx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »